Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

An Open-label, Randomized, Four-way Crossover, Single Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants

To see complete record on, please visit this link

Id: NCT04300621

Organisation Name: Janssen Research & Development, LLC

Overal Status: Completed

Start Date: June 19, 2020

Last Update: September 14, 2020

Lead Sponsor: Janssen Research & Development, LLC

Brief Summary: The purpose of the study in healthy participants is to characterize the plasma pharmacokinetic (PK) profile of different single dose Oral Thin Film (OTF) (S)-ketamine formulations administered sublingually.

  • Healthy

Total execution time in seconds: 0.29399013519287